An investment platform with offices in Asia is backed by a large state-affiliated industrial group. The firm invests across the full company lifecycle, from early and incubation stages through growth and buyout opportunities, deploying capital through multiple funds. For early-stage investments, the firm typically deploys multi-million dollar checks with flexibility depending on the opportunity. The firm evaluates opportunities globally and has invested across key markets including North America, Europe, Israel, and Asia.
Within life sciences and healthcare, the firm focuses on innovative therapeutics, medical devices, and healthcare services. The firm is open to companies across all stages of development, from preclinical through clinical and commercial stages.
From a company and management team perspective, the firm seeks teams with strong industry and clinical expertise, solid scientific foundations, and globally competitive positioning supported by robust intellectual property. The firm leverages close relationships with industrial partners and an established regional network to support portfolio companies in advancing development and expanding into the China market.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment